E R Morgan1, K Laing2, J McCarthy2, F McCrate2, M D Seal2. 1. Department of Medical Oncology, University of Toronto, Toronto, ON; 2. Cancer Care Program, Eastern Health, St. John's, NL;
Abstract
BACKGROUND: Patient education in early-stage breast cancer has been shown to improve patient well-being and quality of life, but it poses a challenge given the increasingly complex regimens and time constraints in clinical practice. Technology-aided teaching in the clinic could help to improve the understanding of adjuvant systemic therapy for patients. In this prospective pilot study, we used a clinician-administered, tablet-based teaching aid to teach patients with early-stage breast cancer about adjuvant systemic therapy. METHODS: Participation was offered to newly diagnosed patients with early-stage breast cancer presenting for their first medical oncology visit at a provincial cancer centre. Participants were shown a tablet-based presentation describing procedures, rationales, risks, and benefits of adjuvant systemic therapy as an adjunct to a discussion with the medical oncologist. After the clinic visit, participants completed a questionnaire measuring satisfaction with the visit and knowledge of the treatment plan discussed. RESULTS: The 25 patients recruited for the study had a mean age of 57 years. An offer of upfront chemotherapy alone was made to 12 participants (48%), chemotherapy with trastuzumab to 4 (16%), and hormonal therapy to 9 (36%). Correct answers to all questions related to treatment knowledge were given by 22 patients (88%). Satisfaction with the clinic visit was high (mean satisfaction score: 4.53 ± 0.1 of a possible 5). CONCLUSIONS: We found that a tablet-based presentation about adjuvant systemic therapy was satisfactory to patients with early-stage breast cancer and that knowledge retention after the clinic visit was high. Tablet-based teaching could be a feasible and effective way of educating patients in the breast oncology clinic and warrants further investigation in randomized studies.
BACKGROUND:Patient education in early-stage breast cancer has been shown to improve patient well-being and quality of life, but it poses a challenge given the increasingly complex regimens and time constraints in clinical practice. Technology-aided teaching in the clinic could help to improve the understanding of adjuvant systemic therapy for patients. In this prospective pilot study, we used a clinician-administered, tablet-based teaching aid to teach patients with early-stage breast cancer about adjuvant systemic therapy. METHODS: Participation was offered to newly diagnosed patients with early-stage breast cancer presenting for their first medical oncology visit at a provincial cancer centre. Participants were shown a tablet-based presentation describing procedures, rationales, risks, and benefits of adjuvant systemic therapy as an adjunct to a discussion with the medical oncologist. After the clinic visit, participants completed a questionnaire measuring satisfaction with the visit and knowledge of the treatment plan discussed. RESULTS: The 25 patients recruited for the study had a mean age of 57 years. An offer of upfront chemotherapy alone was made to 12 participants (48%), chemotherapy with trastuzumab to 4 (16%), and hormonal therapy to 9 (36%). Correct answers to all questions related to treatment knowledge were given by 22 patients (88%). Satisfaction with the clinic visit was high (mean satisfaction score: 4.53 ± 0.1 of a possible 5). CONCLUSIONS: We found that a tablet-based presentation about adjuvant systemic therapy was satisfactory to patients with early-stage breast cancer and that knowledge retention after the clinic visit was high. Tablet-based teaching could be a feasible and effective way of educating patients in the breast oncology clinic and warrants further investigation in randomized studies.
Entities:
Keywords:
Breast cancer; adjuvant systemic therapy; clinical teaching tools; e-learning; mobile technology; patient education; tablet computers
Authors: Sandhya Pruthi; Sarah Rausch; Victor Montori; Julie C Hathaway; Kristin S Vickers Douglas Journal: Breast J Date: 2010-07-13 Impact factor: 2.431
Authors: Michael J Green; Susan K Peterson; Maria Wagner Baker; Gregory R Harper; Lois C Friedman; Wendy S Rubinstein; David T Mauger Journal: JAMA Date: 2004-07-28 Impact factor: 56.272
Authors: Bernard T Lee; Chen Chen; Janet H Yueh; Minh-Doan Nguyen; Samuel J Lin; Adam M Tobias Journal: Ann Surg Oncol Date: 2009-12-29 Impact factor: 5.344
Authors: Hendrik Suhling; Jessica Rademacher; Imke Zinowsky; Jan Fuge; Mark Greer; Gregor Warnecke; Jacqueline M Smits; Anna Bertram; Axel Haverich; Tobias Welte; Jens Gottlieb Journal: PLoS One Date: 2014-03-07 Impact factor: 3.240
Authors: Pearman D Parker; Sue P Heiney; Daniela B Friedman; Tisha M Felder; Robin Dawson Estrada; Eboni Herbert Harris; Swann Arp Adams Journal: J Nurs Educ Pract Date: 2018-01-16
Authors: Kirk D Wyatt; Sarah M Jenkins; Matthew F Plevak; Marcia R Venegas Pont; Sandhya Pruthi Journal: BMC Med Inform Decis Mak Date: 2019-10-21 Impact factor: 2.796